(Q34551970)

3 August 2017

0 references

CHEK2 is a multiorgan cancer susceptibility gene (English)

1 reference

3 August 2017

1

Cybulski C

1 reference

3 August 2017

19

Kurzawski G

1 reference

3 August 2017

24

Lubiński J

1 reference

3 August 2017

8

Byrski T

1 reference

3 August 2017

23

Narod SA

1 reference

3 August 2017

9

Gronwald J

1 reference

3 August 2017

20

Suchy J

1 reference

3 August 2017

3

Huzarski T

1 reference

3 August 2017

2

Górski B

1 reference

3 August 2017

6

Debniak T

1 reference

3 August 2017

4

Masojć B

1 reference

Elżbieta Złowocka-Perłowska

3 August 2017

11

object named as

Zlowocka E

1 reference

3 August 2017

7

Teodorczyk U

1 reference

3 August 2017

16

Medrek K

1 reference

3 August 2017

Mierzejewski M

5

1 reference

3 August 2017

Matyjasik J

10

1 reference

3 August 2017

Lenner M

12

1 reference

3 August 2017

Grabowska E

13

1 reference

3 August 2017

Nej K

14

1 reference

3 August 2017

Castaneda J

15

1 reference

3 August 2017

Szymańska A

17

1 reference

3 August 2017

Szymańska J

18

1 reference

3 August 2017

Oszurek O

21

1 reference

3 August 2017

Witek A

22

1 reference

3 August 2017

language of work or name

English

0 references

publication date

18 October 2004

1 reference

American Journal of Human Genetics

3 August 2017

1 reference

3 August 2017

75

1 reference

3 August 2017

1131-1135

1 reference

3 August 2017

6

1 reference

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

CHEK2 variants associate with hereditary prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

Mutations in CHEK2 associated with prostate cancer risk

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

Frequency of CHEK2*1100delC in New York breast cancer cases and controls

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

CHEK2 variant I157T may be associated with increased breast cancer risk.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

Limited relevance of the CHEK2 gene in hereditary breast cancer.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

A novel founder CHEK2 mutation is associated with increased prostate cancer risk.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

CHEK2 1100delC and colorectal cancer

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1182149

Screening hCHK2 for Mutations

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15492928

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1086/426403

1 reference

3 August 2017

1 reference

3 August 2017

1 reference